T1	Association 0 4	Risk
E1	Association:T1 bc:T3 bc2:T2 snp_int:T5
T2	Cancer 49 62;8 34	breast cancer estrogen receptor-positive
A1	Cancer_Type T2 ER+
T3	Cancer 40 62;8 26	negative breast cancer estrogen receptor-
A2	Cancer_Type T3 ER-
T4	Entity 98 102	2q35
T5	SNP 103 113	rs13387042
R1	SNP_location Arg1:T5 Arg2:T4	
T6	Entity 203 207	2q35
T7	SNP 208 218	rs13387042
R2	SNP_location Arg1:T7 Arg2:T6	
T8	Association 234 248	susceptibility
E2	Association:T8 snp_int:T7 bc:T11
T9	Entity 252 269	estrogen receptor
T10	Entity 271 273	ER
R3	Equiv Arg1:T10 Arg2:T9	
T11	Cancer 252 269;274 297	estrogen receptor -positive breast cancer
A3	Cancer_Type T11 ER+
T12	Entity 388 392	2q35
T13	SNP 393 403	rs13387042
R4	SNP_location Arg1:T13 Arg2:T12	
T14	Entity 433 438	women
R5	Population_assignment Arg1:T13 Arg2:T14	
T16	Spec 989 997	evidence
T17	Association 1001 1012	association
E3	Association:T17 snp_int:T18 bc:T19
R6	Speculation_marker Arg1:E3 Arg2:T16	
T18	SNP 1021 1031	rs13387042
T19	Cancer 1036 1049	breast cancer
T20	Entity 1053 1083	white women of European origin
R8	Population_assignment Arg1:T18 Arg2:T20	
T21	Neg 1252 1255	not
T22	Entity 1264 1267	age
T23	Entity 1271 1280	ethnicity
R9	Risk_Factor Arg1:T18 Arg2:T22	
R10	Risk_Factor Arg1:T18 Arg2:T23	
R11	Negation_marker Arg1:T22 Arg2:T21	
R12	Negation_marker Arg1:T23 Arg2:T21	
T24	Level 1316 1322	higher
T25	Association 1309 1311	it
E4	Association:T25 bc:T19 snp_int:T26
E5	Association:T17 
R14	Equiv Arg1:E4 Arg2:E5	
T26	SNP 1021 1031	rs13387042
R15	Population_assignment Arg1:T26 Arg2:T20	
R16	Speculation_marker Arg1:E4 Arg2:T16	
A4	Level E4 High
R7	Level_marker Arg1:E4 Arg2:T24	
T15	Entity 1397 1418	strong family history
R13	Risk_Factor Arg1:T26 Arg2:T15	
T28	Cancer 1467 1478;1543 1550	ER-positive disease
A5	Cancer_Type T28 ER+
T29	Cancer 1531 1550	ER-negative disease
A6	Cancer_Type T29 ER-
T30	Cancer 1606 1627;1633 1641;1710 1717	progesterone receptor positive disease
T31	Cancer 1698 1717	PR-negative disease
A7	Cancer_Type T31 PR-
A8	Cancer_Type T30 PR+
T32	Entity 1629 1631	PR
T33	Entity 1606 1627	progesterone receptor
R17	Equiv Arg1:T32 Arg2:T33	
T34	SNP 1770 1780	rs13387042
T35	Association 1784 1794	associated
E6	Association:T35 snp_int:T34 bc:T48 bc2:T49
T27	Association 1433 1444	association
E7	Association:T27 bc:T28 bc2:T29 bc3:T30 bc4:T30 snp_int:T18
T36	Effect_Type 26 34	positive
T37	Entity 8 25	estrogen receptor
T38	Organic_inorganic_molecules_affected 0 4	Risk
E8	Organic_inorganic_molecules_affected:T38 Agent:T5 Theme:T37
E9	Organic_inorganic_molecules_affected:T38 Agent:T5 Theme:T37
T39	Neg 40 48	negative
A9	Effect_Type E8 Increase
R18	Effect_type_marker Arg1:E8 Arg2:T36	
R19	Negation_marker Arg1:E9 Arg2:T39	
T40	Organic_inorganic_molecules_affected 234 248	susceptibility
E10	Organic_inorganic_molecules_affected:T40 Agent:T7 Theme:T9
T41	Effect_Type 275 283	positive
A10	Effect_Type E10 Increase
R20	Effect_type_marker Arg1:E10 Arg2:T41	
T42	Organic_inorganic_molecules_affected 1433 1444	association
E11	Organic_inorganic_molecules_affected:T42 Agent:T18 Theme:T43
E12	Organic_inorganic_molecules_affected:T42 Agent:T18 Theme:T33
E13	Organic_inorganic_molecules_affected:T42 Agent:T18 Theme:T33
E14	Organic_inorganic_molecules_affected:T42 Agent:T18 Theme:T43
T43	Entity 1467 1469	ER
T44	Effect_Type 1470 1478	positive
T45	Neg 1534 1542	negative
R21	Effect_type_marker Arg1:E11 Arg2:T44	
A11	Effect_Type E11 Increase
R22	Negation_marker Arg1:E14 Arg2:T45	
T46	Effect_Type 1633 1641	positive
T47	Neg 1701 1709	negative
R23	Effect_type_marker Arg1:E13 Arg2:T46	
A12	Effect_Type E13 Increase
R24	Negation_marker Arg1:E12 Arg2:T47	
T48	Cancer 1805 1816	ER-positive
A13	Cancer_Type T48 ER+
T49	Cancer 1821 1846	ER-negative breast cancer
A14	Cancer_Type T49 ER-
T50	Entity 1850 1864	European women
R25	Population_assignment Arg1:T34 Arg2:T50	
T51	Entity 1805 1807	ER
T52	Effect_Type 1808 1816	positive
T53	Neg 1824 1832	negative
T54	Organic_inorganic_molecules_affected 1784 1794	associated
E15	Organic_inorganic_molecules_affected:T54 Agent:T34 Theme:T51
E16	Organic_inorganic_molecules_affected:T54 Agent:T34 Theme:T51
A15	Effect_Type E15 Increase
R26	Negation_marker Arg1:E16 Arg2:T53	
R27	Effect_type_marker Arg1:E15 Arg2:T52	
R28	Equiv Arg1:T34 Arg2:T18	
